[1] Wilkinson GR. Drug metabolism and variability among patients in drug response[J]. N Engl J Med, 2005, 352(21): 2211-2221. [2] Wijnen PA, Op den Buijsch RA, Drent M, et al. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms[J]. Aliment Pharmacol Ther, 2007, 26(2): 211-219. [3] 易飞, 周宏灏. 天然药对CYP3A的影响[J]. 中国临床药理学与治疗学,2008,13(3): 344-349. [4] Porubsky PR, Meneely KM, Scott EE. Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates[J]. J Biol Chem, 2008, 283(48): 33698-33707. [5] Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol[J]. Free Radic Biol Med, 2008, 44(5): 723-738. [6] Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)[J]. The Oncologist, 2007, 12(8): 927-941. [7] Kim RB. Drugs as P-glycoprotein substrates, inhibitors, and inducers[J]. Drug Metab Rev, 2002, 34(1/2): 47-54. [8] Suzuki H, Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine[J]. Eur J Pharm Sci, 2000, 12(1): 3-12. [9] 毛晓琴, 谢海棠, 周宏灏. 多药耐药蛋白和CYP3A4介导的中草药-西药相互作用[J]. 中国临床药理学与治疗学, 2007, 12(7): 728-734. [10]杜继煜, 白岚, 白宝璋. 茶叶的主要化学成分[J]. 农业与技术, 2003, 23(1): 53-55. [11]Almond LM, Yang J, Jamei M, et al. Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction[J]. Curr Drug Metab, 2009, 10(4): 420-432. [12]Dasgupta A, Reyes MA, Risin SA, et al. Interaction of white and pink grapefruit juice with acetaminophen (paracetamol) in vivo in mice[J]. J Med Food, 2008, 11(4):795-798. [13]Shihana F, Dissanayake D, Dargan P, et al. A modified low-cost colorimetric method for paracetamol (acetaminophen) measurement in plasma[J]. Clin Toxicol(Phila), 2010, 48(1): 42- 46. [14]Letelier ME, Pimentel A, Pino P, et al. Microsomal UDP-glucuronyltransferase in rat liver: oxidative activation[J]. Basic Clin Pharmacol Toxicol, 2005, 96(6): 480-486. [15]Bray BJ, Goodin MG, Inder RE, et al. The effect of retinol on hepatic and renal drug-metabolising enzymes[J]. Food Chem Toxicol, 2001, 39(1): 1-9. [16]Bailey DG, Spence JD, Edgar B, et al. Ethanol enhances the hemodynamic effects of felodipine[J]. Clin Invest Med,1989,12(6): 357-362. [17]Fakhoury M, Litalien C, Medard Y, et al. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age[J]. Drug Metab Dispos, 2005, 33(11): 1603-1607. [18]Marathe PH, Rodrigues AD. Examination of CYP3A and P-glycoprotein-mediated drug-drug interactions using animal models[J]. Methods Mol Biol, 2010, 596: 385-403. [19]Del Amo EM, Heikkinen AT, Monkkonen J. In vitro-in vivo correlation in P-glycoproteinmediated transport in intestinal absorption[J]. Eur J Pharm Sci, 2009, 36(2/3): 200-211. [20]Kim RB. Drug transporters in HIV Therapy[J]. Top HIV Med, 2003, 11(4):136-139. [21]Benet LZ. The drug transporter-metabolism alliance: uncovering and defining the interplay[J]. Mol Pharm, 2009, 6(6):1631-1643. [22]Manov I, Bashenko Y, Hirsh M, et al. Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells[J]. Basic Clin Pharmacol Toxicol, 2006, 99(3): 213-224. [23]Manyike PT, Kharasch ED, Kalhorn TF, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation[J]. Clin Pharmacol Ther, 2000, 67(3): 275-282. [24]Wang EJ, Lew K, Casciano CN, et al. Interaction of common azole antifungals with PGlycoprotein[J]. Antimicrob Agents Chemother, 2002, 46(1): 160-165. [25]Court MH, Duan SX, Von Moltke LL, et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP glucuronosyltransferase isoforms[J]. J Pharmacol Exp Ther, 2001, 299(3): 998-1006. [26]Burchell B. Genetic variation of human udp-glucuronosyltransferase implications in disease and drug glucuronidation[J]. Am J Pharmacogenomics, 2003, 3(1): 37-52. [27]Reiter C, Weinshilboum R. Platelet phenol sulfotransferase activity: Correlation with sulfate conjugation of acetaminophen[J]. Clin Pharmacol Ther, 1982, 32(5): 612-621. [28]Pacifici GM. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: A review of the literature[J]. Int J Clin Pharmacol Ther, 2004, 42(9):488-495. [29]Dahlin DC, Miwa GT, Lu AY, et al. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen[J]. Proc Natl Acad Sci USA, 1984, 81(5):1327-1331. [30]Manyike PT, Kharasch ED, Kalhorn TF, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation[J]. Clin Pharmacol Ther, 2000, 67(3): 275-282. [31]Cheng J, Ma X, Krausz KW, et al. Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity[J]. Drug Metab Dispos, 2009, 37(8): 1611-1621. [32]Paine MF, Hart HL, Ludington SS, et al. The human intestinal cytochrome P450 “pie”[J]. Drug Metab Dispos,2006,34(5): 880-886. [33]van Heeswijk RP, Cooper CL, Foster BC, et al. Effect of high-dose vitamin C on hepatic cytochrome P450 3A4 activity[J]. Pharmacotherapy, 2005, 25(12):1725-1728. [34]EI-Masry EM, Abou-Donia MB. Reversal of P-glycoprotein expressed in Escherichia coli leaky mutant by ascorbic acid[J]. Life Sci, 2003,73(8): 981-991. [35]Ganzera M, Schneider P, Stuppner H. Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes[J]. Life Sci, 2006, 78(8):856-861. [36]Furumiya K, Mizutani T. Inhibition of human CYP3A4, UGT1A6, and P-glycoprotein with halogenated xanthene food dyes and prevention by superoxide dismutase[J]. J Toxicol Environ Health A, 2008, 71(19):1307-1313. [37]Zhao R, Wang W, Zhao L, et al. Effect of volatile oil from nutmeg on liver microsomal cytochrome P450 in mice[J]. Zhongguo Zhong Yao Za Zhi, 2009, 34(4): 447-449. [38]Walsky RL, Obach RS. Validated assays for human cytochrome P450 activities[J]. Drug Metab Dispos, 2004, 32(6): 647-660. [39]Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol[J]. Free Radic Biol Med, 2008, 44(5):723-738. [40]刘滔滔, 梁宁生, 李艳, 等. 长期服用茶多酚对大鼠肝药酶活性的影响[J]. 广西医科大学学报, 2001, 18(3): 301-303. [41]Chen X, Sun CK, Han GZ, et al. Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression[J]. World J Gastroenterol, 2009, 15(15): 1829-1835. |